| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Nasus Pharma Ltd
13G
NSRX · M7071P109
|
15.3% |
11/13/2025
Event 9/30/2025
|
||||
| Dr. Ronnie Hershman | 15.3% | |||||
| Hershman Holdings LLC | 9.9% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.